一个成功治疗胰腺癌的病例(实践观察)

Amir M Ben Ammar, A. L. Ilyushin
{"title":"一个成功治疗胰腺癌的病例(实践观察)","authors":"Amir M Ben Ammar, A. L. Ilyushin","doi":"10.17816/onco456482","DOIUrl":null,"url":null,"abstract":"Objective: In recent years, researchers are increasingly considering the possibility of using immunotherapeutic drugs as part of the antitumor treatment of such patients, which can potentiate the effectiveness of cytostatic therapy. Particular attention is drawn to the combination of interferon- and recombinant tumor necrosis factor-thymosin--1, which can activate an antitumor immune response, stimulate apoptosis of tumor cells, have a direct antiproliferative effect, cause destruction of neoplasm vessels, and stimulate tumor tissue necrosis.Methods: This paper presents the results of a follow-up of 24 patients with histologically confirmed pancreatic carcinoma. Some patients received combined immunotherapy as the only method of treatment, when the possibilities of standard therapy were exhausted, there were serious complications of anticancer treatment, severe concomitant pathology that did not allow the planned treatment to be carried out in full, or when the patient refused to use cytostatics. In other cases, the introduction of immunotherapeutic drugs was carried out against the background of other antitumor treatment of the 1st or 2nd line, prescribed in connection with the progression of the disease.Results: As a result of the use of a combination of interferon- and recombinant tumor necrosis factor-thymosin--1, patients noted an improvement in the tolerability of the main antitumor treatment, additional manifestations of toxicity from the use of immunodrugs were not observed. The existence of an average positive correlation (r=0.57, p=0.0004) between the level of TNF and the value of the Karnofsky index was revealed, indicating that an increase in the content of TNF is accompanied by an increase in the functional activity of patients. According to computed tomography data, in accordance with the RECIST 1.1 criteria, one patient had a partial response of the tumor to the treatment, in 9 - stabilization of the tumor process, in other cases, observation continues.Conclusions: The data presented are of a pilot nature. One of the available observations is presented in this paper as a clinical case.","PeriodicalId":509207,"journal":{"name":"Russian Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A case of successful treatment for pancreatic cancer (observation from practice)\",\"authors\":\"Amir M Ben Ammar, A. L. Ilyushin\",\"doi\":\"10.17816/onco456482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: In recent years, researchers are increasingly considering the possibility of using immunotherapeutic drugs as part of the antitumor treatment of such patients, which can potentiate the effectiveness of cytostatic therapy. Particular attention is drawn to the combination of interferon- and recombinant tumor necrosis factor-thymosin--1, which can activate an antitumor immune response, stimulate apoptosis of tumor cells, have a direct antiproliferative effect, cause destruction of neoplasm vessels, and stimulate tumor tissue necrosis.Methods: This paper presents the results of a follow-up of 24 patients with histologically confirmed pancreatic carcinoma. Some patients received combined immunotherapy as the only method of treatment, when the possibilities of standard therapy were exhausted, there were serious complications of anticancer treatment, severe concomitant pathology that did not allow the planned treatment to be carried out in full, or when the patient refused to use cytostatics. In other cases, the introduction of immunotherapeutic drugs was carried out against the background of other antitumor treatment of the 1st or 2nd line, prescribed in connection with the progression of the disease.Results: As a result of the use of a combination of interferon- and recombinant tumor necrosis factor-thymosin--1, patients noted an improvement in the tolerability of the main antitumor treatment, additional manifestations of toxicity from the use of immunodrugs were not observed. The existence of an average positive correlation (r=0.57, p=0.0004) between the level of TNF and the value of the Karnofsky index was revealed, indicating that an increase in the content of TNF is accompanied by an increase in the functional activity of patients. According to computed tomography data, in accordance with the RECIST 1.1 criteria, one patient had a partial response of the tumor to the treatment, in 9 - stabilization of the tumor process, in other cases, observation continues.Conclusions: The data presented are of a pilot nature. One of the available observations is presented in this paper as a clinical case.\",\"PeriodicalId\":509207,\"journal\":{\"name\":\"Russian Journal of Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Russian Journal of Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17816/onco456482\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/onco456482","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:近年来,研究人员越来越多地考虑将免疫治疗药物作为此类患者抗肿瘤治疗的一部分,以增强细胞抑制疗法的疗效。其中,干扰素和重组肿瘤坏死因子胸腺肽-1的联合应用尤为引人关注,它可以激活抗肿瘤免疫反应,刺激肿瘤细胞凋亡,具有直接抗增殖作用,导致肿瘤血管破坏,刺激肿瘤组织坏死:本文介绍了对 24 例经组织学确诊的胰腺癌患者的随访结果。一些患者接受了联合免疫疗法作为唯一的治疗方法,这是因为标准疗法的可能性已经耗尽,抗癌治疗出现了严重并发症,严重的并发症导致无法完全实施计划的治疗,或者患者拒绝使用细胞抑制剂。在其他情况下,免疫治疗药物的引入是在其他抗肿瘤治疗的第一或第二线治疗的背景下进行的,处方与疾病进展有关:结果:由于联合使用干扰素和重组肿瘤坏死因子胸腺肽-1,患者对主要抗肿瘤治疗的耐受性有所改善,没有观察到使用免疫药物引起的其他毒性表现。TNF水平与卡诺夫斯基指数值之间存在平均正相关(r=0.57,p=0.0004),这表明TNF含量的增加伴随着患者功能活动的增加。根据计算机断层扫描数据,按照 RECIST 1.1 标准,1 名患者的肿瘤对治疗有部分反应,9 名患者的肿瘤进程趋于稳定,其他病例继续观察:本文提供的数据属于试验性质。本文以临床病例的形式介绍了其中一个观察结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A case of successful treatment for pancreatic cancer (observation from practice)
Objective: In recent years, researchers are increasingly considering the possibility of using immunotherapeutic drugs as part of the antitumor treatment of such patients, which can potentiate the effectiveness of cytostatic therapy. Particular attention is drawn to the combination of interferon- and recombinant tumor necrosis factor-thymosin--1, which can activate an antitumor immune response, stimulate apoptosis of tumor cells, have a direct antiproliferative effect, cause destruction of neoplasm vessels, and stimulate tumor tissue necrosis.Methods: This paper presents the results of a follow-up of 24 patients with histologically confirmed pancreatic carcinoma. Some patients received combined immunotherapy as the only method of treatment, when the possibilities of standard therapy were exhausted, there were serious complications of anticancer treatment, severe concomitant pathology that did not allow the planned treatment to be carried out in full, or when the patient refused to use cytostatics. In other cases, the introduction of immunotherapeutic drugs was carried out against the background of other antitumor treatment of the 1st or 2nd line, prescribed in connection with the progression of the disease.Results: As a result of the use of a combination of interferon- and recombinant tumor necrosis factor-thymosin--1, patients noted an improvement in the tolerability of the main antitumor treatment, additional manifestations of toxicity from the use of immunodrugs were not observed. The existence of an average positive correlation (r=0.57, p=0.0004) between the level of TNF and the value of the Karnofsky index was revealed, indicating that an increase in the content of TNF is accompanied by an increase in the functional activity of patients. According to computed tomography data, in accordance with the RECIST 1.1 criteria, one patient had a partial response of the tumor to the treatment, in 9 - stabilization of the tumor process, in other cases, observation continues.Conclusions: The data presented are of a pilot nature. One of the available observations is presented in this paper as a clinical case.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信